Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp.
نویسندگان
چکیده
Among 477 patients with susceptible Enterobacter spp., 49 subsequently harbored third-generation cephalosporin-resistant Enterobacter spp. Broad-spectrum cephalosporins were independent risk factors for resistance (relative risk [OR] = 2.3, P = 0.01); quinolone therapy was protective (OR = 0.4, P = 0.03). There were trends toward decreased risk for resistance among patients receiving broad-spectrum cephalosporins and either aminoglycosides or imipenem. Of the patients receiving broad-spectrum cephalosporins, 19% developed resistance.
منابع مشابه
Detection of β-lactamase-mediated resistance
ß-Lactams are the most widely used antibiotics, and ß-lactamases are the greatest source of resistance to them. Colorimetric tests are good, rapid, indicators of ß-lactamase production and its contingent resistance in Haemophilus, Moraxella and Neisseria spp. They can also be applied to Gram-negative bacilli but are less useful, since the usual question is not whether a ß-lactamase is produced ...
متن کاملبررسی الگوی مقاومت چندگانه و متقاطع انتروباکتریاسه های تولید کننده بتالاکتامازهای وسیع الطیف عامل عفونت های بیمارستانی در بخش های مراقبت ویژه
Background and purpose: Multiple drug resistance in Enterobacteriaceae has restricted the available options for treatment of infections caused by these bacteria. The aim of this study was to investigate the pattern of multidrug resistance and cross-resistance in Enterobacteriaceae causing nosocomial infections in intensive care units during 2014-2015 in eighteen governmental hospitals in Mazand...
متن کاملClinical Pharmacology of Cefepime in Infants and Children
Cefepime is a fourth-generation cephalosporin which is approved in Europe and in the USA. Food and Drug Administration (FDA) approves cefepime in the treatment of febrile neutropenia. Cefepime is active against gram-negative microorganisms such as Escherichia coli, Haemophilus influenzae, Enterobacter, Klebsiella, Morganella, Neisseria, Serratia, and Proteus species. Cefepime is also active aga...
متن کاملDetection of AMPC and ESBL Producers among Enterobacteriaceae in a Tertiary Health Care in, Kano- Nigeria
Resistance to broad spectrum β lactams, mediated by extended spectrum beta lactamase (ESβL) and AmpC βL enzymes is fast spreading in Nigerian hospitals. Production of these enzymes has resulted in treatment failure especially if one of the second or third generation cephalosporins is used. A study was undertaken to determine the prevalence of each enzyme and coproduction of the two enzymes amon...
متن کاملTreatment with a broad-spectrum cephalosporin versus piperacillin-tazobactam and the risk for isolation of broad-spectrum cephalosporin-resistant Enterobacter species.
Receipt of a broad-spectrum cephalosporin is a strong risk factor for isolation of broad-spectrum cephalosporin-resistant Enterobacter species, and yet the risk from other broad-spectrum beta-lactams hydrolyzed by group 1 beta-lactamases has not been well characterized. We compared the risk conferred by broad-spectrum cephalosporins to that conferred by piperacillin-tazobactam, alone or in comb...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Antimicrobial agents and chemotherapy
دوره 45 9 شماره
صفحات -
تاریخ انتشار 2001